Nesrine Chraiet

Interval-compressed chemotherapy in patients with Ewing’s sarcoma: report on feasibility and toxicity from a North African center

Nesrine Kooli, Hajer Ben Mansour, Yosr Zenzri, Yoldez Houcine et autres

Background: Ewing's sarcoma (ES) is the second most common malignant bone tumor in patients under 20 years of age. The "Euro-Ewing 2012" trial established induction therapy with the 2-week-interval VDC/IE (Vincristine-Doxorubicine-Cyclophosphamide/Ifosfamide-Etoposide) as the standard of care. However, real-world data remain limited. We …

Tunisie (code pays fourni par la source)

781P Prognostic factors in locally advanced rectal cancer (LARC) in the ISANOX Trial: Report from a phase II trial

Nesrine Kooli, Hajer Ben Mansour, A. Mokrani, Yosr Zenzri et autres

Tunisie (code pays fourni par la source)

780P Updated results of the ISANOX phase II trial: Neoadjuvant chemotherapy with FOLFIRINOX and short-course radiotherapy in locally advanced rectal cancer

Nesrine Kooli, Hajer Ben Mansour, A. Mokrani, Yosr Zenzri et autres

Tunisie (code pays fourni par la source)

CN73 Toxicity of docetaxel: Comparative study based on gender

H. Mrad, Yosr Zenzri, Hajer Ben Mansour, C. Belfekih Hassen et autres

Tunisie (code pays fourni par la source)

NFKB1 Mutation and Burkitt Lymphoma: At the Crossroads Between Immunodeficiency and Oncogenesis

Eya Bouzidi, Ilhem Ben Fraj, Nesrine Chraiet, Samia Rekaya et autres

Introduction Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder characterized by reduced levels of immunoglobulins and impaired antibody responses, leading to recurrent infections, autoimmunity, and an increased risk of malignancies. One of the most well-recognized genetic causes of CVID is mutations …

Tunisie (code pays fourni par la source)

264P Evaluation of risk scores for post adjuvant endocrine therapy in early breast cancer in a Tunisian population

Ahmed Mokrani, N. Issaad, Nesrine Chraiet, Yosr Zenzri et autres

For endocrine receptor positive breast cancer patients relapse often occurs after the end of 5 years of adjuvant endocrine therapy. Given the high propensity of distant relapse for patients with early luminal breast cancer, stratifying patients based on their risk of late …

124P Disparity of treatment and outcome in adults, young adults and children with Ewing’s sarcoma

Nesrine Kooli, Hajer Ben Mansour, A. Mokrani, Yosr Zenzri et autres

Ewing's Sarcoma (ES) is a rare and aggressive malignancy that predominantly affects children and adolescents, with less favorable outcomes in adults. We aim to determine disparities in treatment approaches and outcomes across age groups.

Tunisie (code pays fourni par la source)

Vaginal Clear Cell Carcinoma In A 12-Year-Old Girl

Cyrine Mokrani, Hajer Ben Mansour, Nesrine Kooli, Yosr Zenzri et autres

Tunisie (code pays fourni par la source)

Vitiligo like lesions induced by novel therapeutic drug ribociclib in metastatic breast cancer patients

Issaad Nefzi, Hajer Ben Mansour, Yosr Zenzri, Khedija Meddeb et autres

Introduction:Cyclin dependent kinase (CDK) 4/6 inhibitors are oral drugs that include Abemaciclib, Ribociclib and Palbociclib. These drugs target the CDK4/6, that acts as a converging point for different growth proliferation and growth arrest signals

Tunisie (code pays fourni par la source)

CN39 Exploring the pleasure of eating within children undergoing chemotherapy

M. Khlif, Hajer Ben Mansour, H. Mrad, Yosr Zenzri et autres

1678P Tunisian couples confronted with breast cancer

M. Khlif, Hajer Ben Mansour, H. Mrad, M. Kacem et autres

Tunisie (code pays fourni par la source)

1676P Sexuality among Tunisian breast cancer survivors

N. Issaad, Yosr Zenzri, Hajer Ben Mansour, Feryel Letaief-Ksontini et autres

Tunisie (code pays fourni par la source)